Insights into Viral Zoonotic Diseases: COVID-19 and Monkeypox

The onset of the COVID-19 pandemic in 2019 and the sporadic occurrences of monkeypox virus infections have presented substantial hurdles to global healthcare. The appearance of these viruses underscores the persistent menace of infectious diseases. Despite notable strides in medical breakthroughs, encompassing the discovery of novel therapeutics, vaccine advancements, and contemporary surveillance approaches, viral outbreaks persist, leading to millions of infections and fatalities. The consecutive nature of these outbreaks compels us to reassess the depth of our comprehension regarding how viruses transmit, their pathogenicity, and their remarkable adaptability, enabling swift survival. This sequence of events also prompts us to scrutinize the effectiveness of existing therapeutic options, the progress of vaccines, and monitoring procedures within the healthcare sector. This review aims to provide an overview of COVID-19 and monkeypox, delving into their pathogenicity, clinical features, treatment modalities, and challenges.